Results 161 to 170 of about 6,477,164 (283)

A Social Disruptiveness-Based Approach to AI Governance: Complementing the Risk-Based Approach of the AI Act. [PDF]

Sci Eng Ethics
Marchiori S, Hopster JKG, Puzio A, Riemsdijk MBV, Kraaijeveld SR, Lundgren B, Viehoff J, Frank LE.   +7 more
europepmc   +1 more source

A local authority’s risk-based approach to principal inspection frequency of structures [PDF]

, 2016
McGregor, Gary, Mickovski, Slobodan
core  

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Lessons from Ethiopian pharmaceutical regulation: a risk-based approach to overcome challenges and unlock opportunities. [PDF]

Front Med (Lausanne)
Hassen HK, Mekasha YT, Tegegne AA, Ozalp Y.   +3 more
europepmc   +1 more source

Feasibility of a Risk-Based Approach to Cataract Surgery Preoperative Medical Evaluation.

JAMA Ophthalmol, 2021
Cuttitta A, Joseph SS, Henderson J, Portney DS, Keedy JM, Benedict WL, Lahti H, Klarr PS, Shtein RM, Lee PP, Kerr E, Mian SI.   +11 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology. [PDF]

Br J Cancer
Gori S, Venturelli F, Carozzi F, Giorgi Rossi P, Del Mistro A, Multisocietal Contributor Group.   +5 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Reply to "Reevaluating thromboprophylaxis in COVID-19 outpatients: the case for a targeted, risk-based approach". [PDF]

Res Pract Thromb Haemost
Di Vece D, Connors JM, Barco S.
europepmc   +1 more source

Evaluation of Data Errors and Monitoring Activities in a Trial in Japan Using a Risk-Based Approach Including Central Monitoring and Site Risk Assessment. [PDF]

Ther Innov Regul Sci, 2021
Kondo H, Kamiyoshihara T, Fujisawa K, Nojima T, Tanigawa R, Fujiwara H, Suganami H, Hayashi Y, Yamaguchi T.   +8 more
europepmc   +1 more source